FDAnews
www.fdanews.com/articles/78769-anika-ends-development-pact-with-ortho-mcneil

ANIKA ENDS DEVELOPMENT PACT WITH ORTHO-MCNEIL

September 2, 2005

Anika Therapeutics Inc. has terminated a development and commercialization contract with a pharmaceutical company for one of its products. Woburn, Mass.-based Anika (NASDAQ: ANIK) said it ended an agreement with a division of New Jersey's Ortho-McNeil Pharmaceuticals to develop and commercialize Anika's hyaluronic acid-based cosmetic tissue treatment. Hyaluronic acid is a naturally occurring substance found in the body.

Boston Business Journal (http://boston.bizjournals.com/boston/stories/2005/08/29/daily51.html/)